Leslie W. Kreis sold $208k of LTRN
owner at Lantern Pharma Inc.. 61,613 shares at an average of $3.38, traded Jun 10, 2025, filed Jun 13, 2025.
Score components
- +12Role10% owner
- +12Trade size$208k at market
- +10Share of holdings soldSold 30% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-059091, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 10, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -3 | $3.40 | $10 | 207,419 | Jun 13, 2025 |
| Jun 11, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -171 | $3.40 | $581 | 207,248 | Jun 13, 2025 |
| Jun 12, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -10,925 | $3.38 | $37k | 196,323 | Jun 13, 2025 |
| Jun 10, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -5 | $3.40 | $17 | 354,625 | Jun 13, 2025 |
| Jun 11, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -293 | $3.40 | $996 | 354,332 | Jun 13, 2025 |
| Jun 12, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -18,678 | $3.38 | $63k | 335,654 | Jun 13, 2025 |
| Jun 10, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -1 | $3.40 | $3 | 54,791 | Jun 13, 2025 |
| Jun 11, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -45 | $3.40 | $153 | 54,746 | Jun 13, 2025 |
| Jun 12, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -2,886 | $3.38 | $9,755 | 51,860 | Jun 13, 2025 |
| Jun 10, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -5 | $3.40 | $17 | 409,291 | Jun 13, 2025 |
| Jun 11, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -338 | $3.40 | $1,149 | 408,953 | Jun 13, 2025 |
| Jun 12, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -21,557 | $3.38 | $73k | 387,396 | Jun 13, 2025 |
| Jun 10, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -2 | $3.40 | $7 | 125,330 | Jun 13, 2025 |
| Jun 11, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -103 | $3.40 | $350 | 125,227 | Jun 13, 2025 |
| Jun 12, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -6,601 | $3.38 | $22k | 118,626 | Jun 13, 2025 |
Related signals
Other insiders at Lantern Pharma Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | Lantern Pharma Inc. | Aaron G.L. Fletcher owner | $208k 61,613 shares | -30% | |
| 35Weak | Lantern Pharma Inc. | Aaron G.L. Fletcher owner | $124k 40,000 shares | -20% | |
| 35Weak | Lantern Pharma Inc. | Leslie W. Kreis owner | $124k 40,000 shares | -20% | |
| 41Moderate | Lantern Pharma Inc. | Aaron G.L. Fletcher owner | $168k 56,237 shares | -26% | |
| 41Moderate | Lantern Pharma Inc. | Leslie W. Kreis owner | $168k 56,237 shares | -26% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.